Cargando…

Explainable ML models for a deeper insight on treatment decision for localized prostate cancer

Although there are several decision aids for the treatment of localized prostate cancer (PCa), there are limitations in the consistency and certainty of the information provided. We aimed to better understand the treatment decision process and develop a decision-predicting model considering oncologi...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jang Hee, Lee, Sungyup, Lee, Byounghwa, Baek, Ock-kee, Washington, Samuel L., Herlemann, Annika, Lonergan, Peter E., Carroll, Peter R., Jeong, Chang Wook, Cooperberg, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352331/
https://www.ncbi.nlm.nih.gov/pubmed/37460568
http://dx.doi.org/10.1038/s41598-023-38162-1
_version_ 1785074490586169344
author Han, Jang Hee
Lee, Sungyup
Lee, Byounghwa
Baek, Ock-kee
Washington, Samuel L.
Herlemann, Annika
Lonergan, Peter E.
Carroll, Peter R.
Jeong, Chang Wook
Cooperberg, Matthew R.
author_facet Han, Jang Hee
Lee, Sungyup
Lee, Byounghwa
Baek, Ock-kee
Washington, Samuel L.
Herlemann, Annika
Lonergan, Peter E.
Carroll, Peter R.
Jeong, Chang Wook
Cooperberg, Matthew R.
author_sort Han, Jang Hee
collection PubMed
description Although there are several decision aids for the treatment of localized prostate cancer (PCa), there are limitations in the consistency and certainty of the information provided. We aimed to better understand the treatment decision process and develop a decision-predicting model considering oncologic, demographic, socioeconomic, and geographic factors. Men newly diagnosed with localized PCa between 2010 and 2015 from the Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting database were included (n = 255,837). We designed two prediction models: (1) Active surveillance/watchful waiting (AS/WW), radical prostatectomy (RP), and radiation therapy (RT) decision prediction in the entire cohort. (2) Prediction of AS/WW decisions in the low-risk cohort. The discrimination of the model was evaluated using the multiclass area under the curve (AUC). A plausible Shapley additive explanations value was used to explain the model’s prediction results. Oncological variables affected the RP decisions most, whereas RT was highly affected by geographic factors. The dependence plot depicted the feature interactions in reaching a treatment decision. The decision predicting model achieved an overall multiclass AUC of 0.77, whereas 0.74 was confirmed for the low-risk model. Using a large population-based real-world database, we unraveled the complex decision-making process and visualized nonlinear feature interactions in localized PCa.
format Online
Article
Text
id pubmed-10352331
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-103523312023-07-19 Explainable ML models for a deeper insight on treatment decision for localized prostate cancer Han, Jang Hee Lee, Sungyup Lee, Byounghwa Baek, Ock-kee Washington, Samuel L. Herlemann, Annika Lonergan, Peter E. Carroll, Peter R. Jeong, Chang Wook Cooperberg, Matthew R. Sci Rep Article Although there are several decision aids for the treatment of localized prostate cancer (PCa), there are limitations in the consistency and certainty of the information provided. We aimed to better understand the treatment decision process and develop a decision-predicting model considering oncologic, demographic, socioeconomic, and geographic factors. Men newly diagnosed with localized PCa between 2010 and 2015 from the Surveillance, Epidemiology, and End Results Prostate with Watchful Waiting database were included (n = 255,837). We designed two prediction models: (1) Active surveillance/watchful waiting (AS/WW), radical prostatectomy (RP), and radiation therapy (RT) decision prediction in the entire cohort. (2) Prediction of AS/WW decisions in the low-risk cohort. The discrimination of the model was evaluated using the multiclass area under the curve (AUC). A plausible Shapley additive explanations value was used to explain the model’s prediction results. Oncological variables affected the RP decisions most, whereas RT was highly affected by geographic factors. The dependence plot depicted the feature interactions in reaching a treatment decision. The decision predicting model achieved an overall multiclass AUC of 0.77, whereas 0.74 was confirmed for the low-risk model. Using a large population-based real-world database, we unraveled the complex decision-making process and visualized nonlinear feature interactions in localized PCa. Nature Publishing Group UK 2023-07-17 /pmc/articles/PMC10352331/ /pubmed/37460568 http://dx.doi.org/10.1038/s41598-023-38162-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Han, Jang Hee
Lee, Sungyup
Lee, Byounghwa
Baek, Ock-kee
Washington, Samuel L.
Herlemann, Annika
Lonergan, Peter E.
Carroll, Peter R.
Jeong, Chang Wook
Cooperberg, Matthew R.
Explainable ML models for a deeper insight on treatment decision for localized prostate cancer
title Explainable ML models for a deeper insight on treatment decision for localized prostate cancer
title_full Explainable ML models for a deeper insight on treatment decision for localized prostate cancer
title_fullStr Explainable ML models for a deeper insight on treatment decision for localized prostate cancer
title_full_unstemmed Explainable ML models for a deeper insight on treatment decision for localized prostate cancer
title_short Explainable ML models for a deeper insight on treatment decision for localized prostate cancer
title_sort explainable ml models for a deeper insight on treatment decision for localized prostate cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352331/
https://www.ncbi.nlm.nih.gov/pubmed/37460568
http://dx.doi.org/10.1038/s41598-023-38162-1
work_keys_str_mv AT hanjanghee explainablemlmodelsforadeeperinsightontreatmentdecisionforlocalizedprostatecancer
AT leesungyup explainablemlmodelsforadeeperinsightontreatmentdecisionforlocalizedprostatecancer
AT leebyounghwa explainablemlmodelsforadeeperinsightontreatmentdecisionforlocalizedprostatecancer
AT baekockkee explainablemlmodelsforadeeperinsightontreatmentdecisionforlocalizedprostatecancer
AT washingtonsamuell explainablemlmodelsforadeeperinsightontreatmentdecisionforlocalizedprostatecancer
AT herlemannannika explainablemlmodelsforadeeperinsightontreatmentdecisionforlocalizedprostatecancer
AT lonerganpetere explainablemlmodelsforadeeperinsightontreatmentdecisionforlocalizedprostatecancer
AT carrollpeterr explainablemlmodelsforadeeperinsightontreatmentdecisionforlocalizedprostatecancer
AT jeongchangwook explainablemlmodelsforadeeperinsightontreatmentdecisionforlocalizedprostatecancer
AT cooperbergmatthewr explainablemlmodelsforadeeperinsightontreatmentdecisionforlocalizedprostatecancer